Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Tobacco Control
|
March 4, 2022
Plain tobacco packaging: progress, challenges, learning and opportunities
Crawford Moodie, Janet Hoek, David Hammond, et al.
Pediatrics
|
January 3, 2018
Protecting Young Children From Tobacco Smoke Exposure: A Pilot Study of Project Zero Exposure
Laura Rosen, Nurit Guttman, Vicki Myers, et al.
Health Research Policy and Systems
|
May 29, 2010
A framework for developing an evidence-based, comprehensive tobacco control program
Laura Rosen, Elliot Rosenberg, Martin McKee, et al.
British Journal of Clinical Pharmacology
|
May 15, 2021
Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1A
Wei Yin, Dimitrios Arkilo, Polyna Khudyakov, et al.
Journal of Clinical Pharmacology
|
July 1, 2006
Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers
Susie Xiujiang Li, Edward Pequignot, Deborah Panebianco, et al.
Journal of Alzheimer'S Disease : JAD
|
October 22, 2016
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease
Gvido Cebers, Robert C Alexander, Samantha Budd Haeberlein, et al.
Journal of Sleep Research
|
March 19, 2023
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals
Rebecca Evans, Haruhide Kimura, Masato Nakashima, et al.
Sleep
|
February 2, 2013
Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men
Hong Sun, William P Kennedy, Darren Wilbraham, et al.
Psychopharmacology
|
August 15, 2025
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial
Peter C T Hawkins, Adam J Schwarz, James M Stone, et al.
Translational Psychiatry
|
May 28, 2021
Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulation
Patricio O'Donnell, Francis M Dijkstra, Ugur Damar, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Tobacco Control
|
March 4, 2022
Plain tobacco packaging: progress, challenges, learning and opportunities
Crawford Moodie, Janet Hoek, David Hammond, et al.
Pediatrics
|
January 3, 2018
Protecting Young Children From Tobacco Smoke Exposure: A Pilot Study of Project Zero Exposure
Laura Rosen, Nurit Guttman, Vicki Myers, et al.
Health Research Policy and Systems
|
May 29, 2010
A framework for developing an evidence-based, comprehensive tobacco control program
Laura Rosen, Elliot Rosenberg, Martin McKee, et al.
British Journal of Clinical Pharmacology
|
May 15, 2021
Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1A
Wei Yin, Dimitrios Arkilo, Polyna Khudyakov, et al.
Journal of Clinical Pharmacology
|
July 1, 2006
Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers
Susie Xiujiang Li, Edward Pequignot, Deborah Panebianco, et al.
Journal of Alzheimer'S Disease : JAD
|
October 22, 2016
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease
Gvido Cebers, Robert C Alexander, Samantha Budd Haeberlein, et al.
Journal of Sleep Research
|
March 19, 2023
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals
Rebecca Evans, Haruhide Kimura, Masato Nakashima, et al.
Sleep
|
February 2, 2013
Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men
Hong Sun, William P Kennedy, Darren Wilbraham, et al.
Psychopharmacology
|
August 15, 2025
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial
Peter C T Hawkins, Adam J Schwarz, James M Stone, et al.
Translational Psychiatry
|
May 28, 2021
Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulation
Patricio O'Donnell, Francis M Dijkstra, Ugur Damar, et al.
Page
of 5